The onset and aggressiveness of cancer are related to the abnormal behavior of certain genes, known as oncogenes. The best-known of these alterations is mutation, but it is not the only one. Sometimes ...
With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...
The concept of "good fats" and "bad fats" has influenced diet trends, public health policy, and biomedical research for ...
How CRISPR and functional genomics are used to establish causality, understand disease mechanisms and guide early drug ...
The onset and aggressiveness of cancer are related to the abnormal behaviour of certain genes, known as oncogenes. The best-known of these alterations ...
Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...
The Times of Israel on MSN
Israeli researchers identify gene that causes elusive neurodevelopmental disorder
Using CRISPR, Hebrew University of Jerusalem team finds PEDS1 enzyme linked to reduced brain size; study maps 331 genes ...
Among those Robert F. Kennedy Jr. recently named to a federal autism committee are people who tout dangerous treatments and ...
Key takeawaysTau is the most common protein that aggregates in neurodegeneration diseases. However, researchers had not ...
News Medical on MSN
Research uncovers why certain brain cells are more resilient to tau protein buildup
New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the ...
Scientists discovered why some neurons resist tau toxicity, identifying CRL5SOCS4 as a crucial defense and linking ...
Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results